De novo variants in KDM2A cause a syndromic neurodevelopmental disorder
Anderson E, Drukewitz S, Kour S, Chimata A, Rajan D, Schönnagel S, Stals K, Donnelly D, O'Sullivan S, Mantovani J, Tan T, Stark Z, Zacher P, Chatron N, Monin P, Drunat S, Vial Y, Latypova X, Levy J, Verloes A, Carter J, Bonner D, Shankar S, Bernstein J, Cohen J, Comi A, Carere D, Dyer L, Mullegama S, Sanchez-Lara P, Grand K, Kim H, Ben-Mahmoud A, Gospe S, Belles R, Bellus G, Lichtenbelt K, Oegema R, Rauch A, Ivanovski I, Mau-Them F, Garde A, Rabin R, Pappas J, Bley A, Bredow J, Wagner T, Decker E, Bergmann C, Domenach L, Margot H, Lemke J, Jamra R, Hentschel J, Mefford H, Singh A, Pandey U, Platzer K
medRxiv. 2025.

Urine N-Acetylaspartate Distinguishes Phenotypes in Canavan Disease
Nagy A, Eichler F, Bley A, Bredow J, Fay A, Townsend E, Leiro B, Shaywitz A, Laforet G, Crippen-Harmon D, Williams R
HUM GENE THER. 2025;36(1-2):45-56.

Deep Intronic SVA_E Retrotransposition as a Novel Factor in Canavan Disease Pathogenesis
Weiß M, Selig M, Friedrich J, Wierczeiko A, Diederich S, Sigel H, Bredow J, Eichler F, Nagy A, Seyler D, Holthöfer L, Gerber S, Schweiger S, Linke M, Bley A
HUM GENE THER. 2025 [Epub ahead of print].

Letzte Aktualisierung aus dem FIS: 28.08.2025 - 05:13 Uhr